Boundary Capital
Impact investorNorthampton · Seed–Series A · 5 people tracked
Find your way into Boundary Capital
Sign up to see every warm intro you have to Boundary Capital
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Boundary Capital team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Investment thesis
Boundary Capital backs high-growth private technology companies that it believes can positively impact millions of lives. The firm's team brings blue-chip commercial and academic experience across life sciences, artificial intelligence, and engineering, drawing on a track record of founding, investing in, and exiting multiple businesses. This combined operator and investor background informs a focus on technology-driven ventures with significant potential for scale and societal impact.
Source: firm website, verified Sep 24, 2026.
Team · 5 people
from the firm's website & public directoriesWhat they invest in
from 4 of 30 portfolio companiesAI & Machine Learning ×2Deep Tech ×2Biotech ×1Digital Health ×1EdTech ×1Fintech ×1Healthtech ×1Medical Devices ×1
HQs:United Kingdom×2
Investments · 30 tracked
founders shown can be your intro pathBy year:2021 · 12018 · 22013 · 25 dated
Bodyswaps provides immersive learning experiences, likely VR or virtual simulations, for educational institutions including further education colleges and apprenticeship providers.
AI & Machine LearningEdTechSaaSLondon, GB
Christophe Mallet(Chief Executive Officer)inTom Szirtes(Chief Product & Technology Officer)inJulien Denoel(Chief Operations Officer)in
Co-investorsHaatchUfi VocTech Trust
Glyconics develops medical diagnostic devices using spectroscopy (light-with-matter technology) to support low-cost medical diagnosis and disease management for patients and healthcare practice.
Deep TechDigital HealthHealthtechMedical Devices
Andrew Round(Chief Executive Officer (ad interim))Dr. Päivi Maria Paldánius(Chief Medical Officer & Chief Operating Officer)Sebastien Cuvelier Mussalian(Chief Technology Officer)Dr. Phil Taday(Head of R&D)Paul Jesson(Chief Finance Officer)
Co-investorsAnglia Capital GroupDeepbridge Capital
This page is a podcast interview/article about Empirical Ventures, not a company website.
AI & Machine LearningDeep TechFintechLondon, GB
Johnathan Matlock(Co-founder and General Partner)
Advanced wound care therapy delivering continuous topical oxygen to accelerate healing.
Michael Clancy(Interim CEO)
Co-investorsAmadeus Capital Partners
Supplies machines and supplies that kill weeds without using herbicides.
Co-investorsCalculus Capital Ltd.Calculus
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
BC ABBC Dymag MAIN HIGH RESBC EchionBC glyconicsBitcoin Farming AdvisoryBusinessBusiness MatchingBusiness StrategyCelixirDesktop GeneticsFinancialImage ScanInductosenseInvestingInvestmentMarket ResearchMeetingMergerMerger AcquisitionPlanningResearchStockTorsionTorsion Information SecurityWarwick Analytics
Exits · 1
1 acquisitionsDesktop Geneticsacq. by Celixir
Portfolio news
latest coverage across their companiesHardman & Co · hardmanandco.com · Apr 29, 2026
Principals & officers · per Companies House
what is this? ⓘDirector · British · since 2009
Daniel Peter Somers — 75–100% of shares, 75–100% of voting rights, right to appoint and remove directors, significant influence or control
Frequently asked questions
- How many investments has Boundary Capital made?
- Boundary Capital has 30 tracked investments, 1 of which have exited.
- What stage does Boundary Capital invest at?
- Boundary Capital invests at the Seed, Series A stages.
- What is Boundary Capital's typical check size?
- Boundary Capital typically writes checks of $190.5K – $635K.
- What sectors does Boundary Capital focus on?
- Boundary Capital focuses on AI & Machine Learning, Biotech, Cleantech, Climate Tech, Data & Infrastructure, Deep Tech, FoodTech, Healthtech, Impact & Social Good, Longevity.
- Where is Boundary Capital located?
- Boundary Capital is headquartered in Northampton, GB.
- Who does Boundary Capital co-invest with?
- Boundary Capital most often shares deals with Amadeus Capital Partners, Calculus Capital Ltd., Haatch, among 4 tracked co-investors.
Media · Podcasts & interviews
featuring the teamGrowthInvest Adviser Hour: Interview with Dan Somers of Boundary Capital
Boundary Capital · Dan
Images
Co-investors · 1
Sana Capital invests in growth-stage healthcare businesses at the intersection of services and technology, focusing on sustainable solutions that improve access, outcomes, and costs while promoting health equity in underserved communities.
Firms observed investing alongside Boundary Capital, from public investor directories. Shared companies are the overlap with Boundary Capital's recorded portfolio.
Similar investors
Everywhere Ventures is an early-stage venture firm that writes pre-seed checks and is backed by a community of founder and operator LPs.
Hawktail is an investment firm backing early-stage companies across technology, life sciences, climate, and consumer sectors.
Possible Ventures is an early-stage venture firm backing mission-driven founders using frontier technology to solve major challenges across climate, energy, health and society.
Sofinnova Partners is a life sciences venture capital firm investing across the value chain from seed to later stage, with a focus on healthcare and sustainability. It backs companies in biopharma, medtech, digital medicine, agriculture and industrial processes.




















